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Abstract 32 
 33 
From being a metal with very limited natural distribution, indium (In) has recently 34 
become disseminated throughout the human society. Little is know of how In compounds 35 
behave in the natural environment, but recent medical studies link exposure to In compounds 36 
to elevated risk of respiratory disorders. Animal tests suggest that exposure may lead to more 37 
widespread damage in the body, notably the liver, kidneys and spleen. In this paper, we 38 
investigate the solubility of the most widely used In compound, indium-tin oxide (ITO) in 39 
simulated lung and gastric fluids in order to better understand the potential pathways for 40 
metals to be introduced into the bloodstream. Our results show significant potential for 41 
release of In and tin (Sn) in the deep parts of the lungs (artificial lysosomal fluid) and 42 
digestive tract, while the solubility in the upper parts of the lungs (the respiratory tract or 43 
tracheobronchial tree) is very low.  44 
Our study confirms that ITO is likely to remain as solid particles in the upper parts of 45 
the lungs, but that particles are likely to slowly dissolve in the deep lungs. Considering the 46 
prolonged residence time of inhaled particles in the deep lung, this environment is likely to 47 
provide the major route for uptake of In and Sn from inhaled ITO nano- and microparticles. 48 
Although dissolution through digestion may also lead to some uptake, the much shorter 49 
residence time is likely to lead to much lower risk of uptake. 50 
51 
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1. Introduction 52 
There is increasing evidence to suggest that indium (In) compounds may be harmful 53 
to human health, yet the potential transfer mechanisms into the human body are very poorly 54 
understood. While in vivo tests on mice and rats have shown that In-phosphide, In-arsenide 55 
In-trichloride and In-acetate have toxic and carcinogenic effects (Chapin et al., 1995; Oda, 56 
1997; Tanaka, 2004, Lee et al., 2016), the most widely used compound, indium-tin oxide 57 
(ITO), was until recently considered to be comparably inert (Fowler et al., 2009). However, 58 
studies by Homma et al. (2003) and Cummings et al. (2010, 2016) linked health problems 59 
and fatalities among factory workers to their exposure to ITO. Indeed, mounting evidence 60 
from recent research suggests that exposure to ITO can be directly linked to lung disorders, 61 
such as pulmonary alveolar proteinosis, pulmonary fibrosis, emphysema, and 62 
pneumothoraces (Chonan et al., 2007; Lison et al., 2009; Nakano et al., 2009; Omae et al., 63 
2011, Cummings et al., 2012, 2016; Badding et al., 2015, 2016). Experiments on rats by 64 
Nagano et al. (2011) furthermore indicate that exposure to ITO may linked to increased risk 65 
of malignant lung tumors. 66 
Despite the very low solubility of ITO, Chonan et al. (2007) and Hamaguchi et al. 67 
(2008) found elevated concentrations of In in serum from current and former workers 68 
exposed to ITO at a factory in Japan. These studies suggest that the ITO does not remain 69 
entirely inert upon intake, but that In is released to circulate more widely within the human 70 
body. Very little research has been carried out to document any wider health effects, but 71 
Omura et al. (2002) suggested that exposure to ITO may lead to testicular toxicity in 72 
hamsters. Bomhard (2016), however, suggested that damage to the male sexual organs may 73 
be a secondary effect from the lung damage. In more general terms, Smith et al. (1978) and 74 
Blazka (1998) suggest that chronic exposure to In may lead to weight loss and damage to the 75 
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liver, kidneys and spleen, and it is likely that once In from ITO enters the bloodstream, it may 76 
have similar effects as ionic or colloidal In compounds (cf., Smith et al., 1978, Blazka, 1998).  77 
In this study, we report the results of in vitro experiments to examine the dissolution 78 
behavior of ITO in simulated lung and gastric fluids and discuss the potential transfer 79 
mechanisms for In and associated tin (Sn) into the human body.  80 
 81 
2. Background 82 
Indium is a metal that belongs to group 13 of the periodic table along with boron, 83 
aluminum, gallium and thallium. The principal oxidation state is trivalent and the effective 84 
ionic radius for In
3+
 in 8-fold coordination is 0.092 nm (Shannon, 1976), which is 85 
intermediate between scandium and the lanthanides. The metal is predominantly found in 86 
sulfide minerals that are unstable under oxidizing conditions at the Earth’s surface. 87 
Consequently it is likely to be released during acid mine drainage. Tin in contrast occurs 88 
principally in the form of cassiterite (SnO2) which is very stable in the environment and tends 89 
to be residual after weathering.  90 
Indium is very rare in the natural environment and has historically had very little use 91 
in society. Tin in contrast, although also naturally rare, has a history of human exploitation 92 
that dates back millennia, and it’s environmental and health effects are much better 93 
constrained. However, through the distribution of mobile electronic devices, flat-screen 94 
televisions and computer displays, In has over the last decade appeared extensively in the 95 
human environment (White and Hemond, 2012). As a consequence, the global potential for 96 
exposure has increased dramatically, and concerns about environmental and health issues 97 
must be considered with some urgency.   98 
The most widespread use of In is in sintered indium-tin oxide (ITO), which is applied 99 
as a conductive coating on flat-screen liquid crystal displays in mobile electronic devices, 100 
  6 
computer monitors and televisions. Indium is also used in lead-free solders, light-emitting 101 
diodes, and copper-indium-gallium-selenide (CIGS) photovoltaic panels. As flat screen 102 
displays are now almost completely replacing cathode-ray televisions and computer monitors, 103 
and mobile electronic devices are becoming more widespread, ITO can be expected to start 104 
appearing in the domestic waste stream in significant quantities. Flat screen displays contain 105 
on average 234 mg In per square meter (Böni and Widmer, 2011); the average lifetime of a 106 
mobile electronic device is estimated to less than 5 years, while the lifetime of a domestic flat 107 
panel television or computer monitor is estimated to 9 years (USEPA, 2011). While a 108 
significant proportion of computer monitors are recycled (38%), televisions and mobile 109 
telephones have very poor recycling statistics (17% and 8% respectively, USEPA, 2011) and 110 
mostly end up in the household waste. The global end-of-life recycling rate for In was 111 
estimated to be less than 1% in 2011 (Graedel et al., 2011). 112 
During the lifetime of a flat-screen display, the ITO is not exposed, and it therefore 113 
does not pose immediate risk to general consumers. Apart from during manufacture, the main 114 
risks for release of ITO particles would be during recycling and disposal of the devices, 115 
where ITO coated glass is typically mechanically abraded before In is recovered by chemical 116 
leaching (Zeng et al, 2015; Zhang et al., 2015). 117 
The biological residence time of ITO particles in the body is a significant parameter to 118 
consider in relation to intake. Only a small fraction of insoluble particles are likely to be 119 
retained within the upper respiratory tract or tracheobronchial tree (Patrick and Stirling, 1977; 120 
Watson and Brain, 1979; Gore and Patrick, 1982). However, as particles are introduced to the 121 
deep lung environment (the bronchioles and alveoli), they are likely to accumulate over 122 
extensive periods of time. Radford and Martell (1977) estimated that the residence time for 123 
insoluble particles in bronchial tissue derived from cigarette smoke amounted to 3 to 5 124 
months. The digestive system, in contrast, has a much shorter transit time, with solid particles 125 
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being excreted typically after one to three days (Daugherty and Mrsny, 1999). Morrow et al. 126 
(1957) determined the biological half-life of In2O3 in rats (administrated orally or by 127 
inhalation) to be in the order of 9-10 days, however, a recent study by Amata et al. (2015) 128 
suggests that the actual residence times of In in humans may be in the order of 8 years. 129 
The United States recommended exposure limits in air are 0.1 mg/m
3
 In and 2 mg/m
3
 130 
inorganic Sn (NIOSH, 1981), which with an inhalation rate of 20-25 m
3
/day for an average 131 
weight adult male (Brochu et al., 2006) would equate to a maximum accumulation in the 132 
lungs of 0.67-0.83 mg In for an eight hour working day (probably as high as 1 mg In for 133 
obese adults). With less than 10 wt% SnO2, the inhalation of Sn from ITO is much less of an 134 
issue. The regulated exposure limit for In in Japan is much more restrictive at 0.0003 mg/m
3
 135 
(MHLW, 2010). The United States minimal risk level for oral intake of inorganic Sn is 0.3 136 
mg/kg/day (ATSDR, 2016) while no safe level appears to have been identified for In. 137 
 138 
3.  Materials and Methods 139 
For this study, we used ITO powder (<44 µm, 325 mesh, ≥ 99.99% purity trace metal 140 
basis, Sigma Aldrich 494682-25G, CAS 50926-11-9:d 1.2) listed to have a composition of 90 141 
wt% In2O3 and 10 wt% SnO2. The powder is similar in composition and particle size to the 142 
material used to produce ITO sputtering targets (Falk, 2012). The production of sputtering 143 
targets involves the densification of the ITO particles under pressure and at high temperature 144 
to form a granular solid with or without binders or additives (Falk, 2012). During sputtering, 145 
nanoparticles are released through heating of the target to deposit as a thin conductive coating 146 
on the substrate (Tuna et al., 2010). The coating consists of nanoparticles that are typically 147 
tens of nanometers across (Kim et al., 2000). 148 
The powder was investigated by powder X-ray diffraction (XRD) and electron-probe 149 
microanalysis (EPMA) at Camborne School of Mines, University of Exeter, to establish the 150 
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structure and variability and particularly to confirm that the material had been sintered. The 151 
XRD was conducted on a Siemens D5000 equipped with the Bruker Topas software using the 152 
JCPDS database (ICDD, 2004). The EPMA analysis was carried out on the JEOL JXA-8200 153 
using a 30 nA electron beam accelerated to 15 kV and wavelength-dispersive X-ray 154 
spectrometers. Results were quantified with tin metal, indium-arsenide, and wollastonite 155 
standards using the CITZAF routine (Armstrong, 1995). 156 
Dissolution experiments were carried out in screw-capped polypropylene beakers 157 
(SCP Science DigiTUBES, product 010-500-261). Samples were prepared in triplicate with a 158 
procedural blank for each set. Experiments were designed to simulate key environments that 159 
are considered to be significant routes for particle intake. A set of control experiments were 160 
carried out with ITO in deionised water (purified with an Elga/Veolia Purelab Flex system). 161 
The gastric environment was simulated with the physiologically based extraction test 162 
(PBET) solution of Ruby et al. (1996), however our experiments were conducted without 163 
suspended particles or gas flow. Tests were conducted for up to four hours, exceeding the 164 
maximum residence time of food in a child’s stomach (Ruby et al., 1996). The pH of the 165 
solution was adjusted to 4 using concentrated HCl, as this value was considered intermediate 166 
between the conditions of fasting and full. A separate test was carried out with trypsin in 167 
deionised water at neutral pH, as a simplistic way of testing if digestive enzymes may 168 
facilitate further dissolution.  169 
The lung environment was explored using the formulations of Colombo et al. (2008): 170 
Gamble’s solution is used to simulate the conditions as ITO particles are inhaled (in the upper 171 
respiratory tract and tracheobronchial tree), while artificial lysosomal fluid (ALF) is 172 
considered to replicate the more acidic conditions in the deep lung (bronchioles and alveoli). 173 
Stock solutions (Table 1) were prepared as specified by Ruby et al. (1996) and 174 
Colombo et al. (2008). Particular care was taken to add the components of Gamble’s solution 175 
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in the correct order to avoid salt precipitation. All plastic ware was soaked in dilute HNO3, 176 
rinsed in deionised water and oven dried prior to use in the experiments.  177 
Experiments were carried out in triplicate using separate beakers (rather than aliquots 178 
from a single beaker) with a procedural blank for each set of three samples. For each 179 
experiment, 50 mg of ITO powder was weighed into the polypropylene beakers and 10 ml of 180 
the required stock solution added (time zero) using an Eppendorf Research Plus® pipette 181 
with non sterile, single use pipette tips. After addition of the fluids, the experiments were 182 
sealed, gently swirled to ensure maximum wetting of the ITO powder without leaving ITO 183 
particles on the beaker walls, and transferred to an oven at 37ºC. The gastric experiments 184 
were carried out with residence times of up to 4 hours, while the lung experiments extended 185 
to 480 hours. A separate experiment was conducted to test the influence of enzymes on the 186 
digestion, for this experiment, 150 mg ITO and 50 mg trypsin (from porcine pancreas, Sigma, 187 
T4799-5G, Lot# 110M7362V) was weighed into the beakers and 25ml of de-ionised water 188 
added. The beakers were swirled to ensure complete wetting of the ITO powder and trypsin 189 
and placed in an oven at 37ºC. These experiments were carried out with residence times of up 190 
to >200 hours.  191 
At the termination of each experiment, three sample beakers and one blank were 192 
collected and the solution immediately vacuum filtered through a single-use 0.45 µm Teflon 193 
membrane (SCP Science DigiFILTER, product 010-500-070) and stored at room temperature 194 
prior to analysis. None of the plastic ware was re-used. 195 
The samples were analyzed for 
28
Si, 
39
K, 
56
Fe, 
115
In and 
118
Sn by the Agilent 7700x 196 
quadrupole inductively-coupled mass spectrometer (ICP-MS) at Camborne School of Mines, 197 
University of Exeter using 
45
Sc as internal standard. Samples were introduced in undiluted 198 
form using an Agilent ASX-520 autosampler. The ICP-MS was fitted with a Peltier cooled 199 
Scott type spray chamber and an inert PTFE sample introduction system. Indium and Sn were 200 
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measured with helium as a collision cell gas to suppress polyatomic mass interferences. The 201 
CeO
+
/Ce
+
 was 0.136% and the Ce
2+
/Ce
+
 was 1.372%. 202 
The interference of 
115
Sn (0.34% of the natural abundance of Sn) on 
115
In was 203 
negligible (< 0.14 ppb) at the measured concentrations. 
28
Si and 
56
Fe were used as monitors 204 
of potential contamination through handling of reagents and beakers, the Si was 205 
systematically below 2µg/g and Fe below 0.5µg/g. The internal standard recovery was 96.6 ± 206 
14.2 %) except for Gamble’s solution (117.6 ± 9.0 %). The instrument was calibrated with 207 
1.6, 8, 40, 200, 1000 and 2000 µg/kg solutions, while a 40 µg/kg standard solutions was 208 
tested after every 12 analyses to monitor instrument drift. After each analysis, the sample 209 
introduction system was flushed with deionized water followed by dilute HNO3 and a further 210 
wash with deionized water. No carryover was observed for the measured metals. Time (t)  is 211 
reported in hours (hrs) and concentrations in parts per billion (ppb, µg/kg) and parts per 212 
million (ppm, mg/kg). Element ratios are reported by weight. Errors are reported at the 2σ 213 
level. 214 
 215 
4. Results 216 
The ITO powder consists of irregularly shaped particles of 10-50 µm that commonly 217 
are hollow and have large surface to mass ratios (Figure 1). X-ray diffraction confirmed the 218 
powder to be composed of Sn-doped In2O3 with distinct signals also for discrete SnO2. No 219 
signals were observed for In2SnO5 or In4Sn3O12 (Kim et al., 2006; Heward and Swenson, 220 
2007). Spot analysis by EPMA confirmed the SnO2 content of the tin-doped indium oxide to 221 
vary between 2.6 and 8.0 wt% (average 3.0 wt%, n=26) and also confirmed the presence of 222 
discrete SnO2 particles that are generally less than 5µm across. The only impurity detected 223 
was silicon dioxide (SiO2) which occurs throughout at 0.4 wt% and locally reaches 2 wt%. 224 
The compositions are consisted with material that has been sintered at temperatures in excess 225 
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of 1000 °C (Heward and Swenson, 2007), and is as such similar to industrial ITO powder 226 
used for the production of sputtering targets. The wall thicknesses of the individual ITO 227 
particles are up to to 3µm, which is generally thicker than the average 125 nm for ITO 228 
coatings (Böni and Widmer, 2011). So while the powder is compositionally and structurally 229 
similar to industrial ITO, the greater wall thicknesses lead to lower expected surface to 230 
volume ratios than for particles liberated from ITO coatings. The powder furthermore 231 
displays no signs of having been subjected to the densification that is involved in the 232 
production of ITO sputtering targets. The particle sizes and shapes therefore differ to those 233 
that can be expected to be released from ITO sputtering targets or ITO coatings during 234 
production or recycling. We consider that the structural and compositional similarities are 235 
reasonable matches to industrial ITO. The particle size differences and lack of densification, 236 
however, are likely to lead to minor differences in the dissolution kinetics. Although the 237 
dissolution speed may differ, we have no reason to believe that the metal concentrations in 238 
the fluids would be substantially different. 239 
The results of the dissolution experiments are presented in Figures 2-7 and the 240 
supplementary data file. As per design, all samples had significant excess of undissolved ITO 241 
at the termination of the experiments. Since partial dissolution is a fractional process, it is 242 
appropriate at least as a first approximation, to consider the dissolution curves as power 243 
functions (cf., Lánský and Weiss, 2003). Our results show very limited solubility of ITO in 244 
deionized water and under simulated upper respiratory tract conditions (Gamble’s solution) 245 
but significant solubility in the simulated deep lung (ALF) and digestive (PBET) 246 
environments. In deionized water (Figure 2), In concentrations stabilized at 134 ± 47 ppb in 247 
less than 18 hours while Sn concentrations systematically remained below 0.2 ppb. Both 248 
display decreasing concentrations with time, along the equations In (ppb) = 253 t
-0.15 
and Sn 249 
(ppb) = 8.59 t
-1.80
, which can be explained by adsorption to the plastic containers (Robertson, 250 
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1968; Smith, 1973). The In blank was measured at 0.18 ± 0.16 ppb while the Sn blank 251 
remained below 0.01 ppb. 252 
Under simulated upper respiratory tract conditions (Figure 3), concentrations of In 253 
and Sn remained very low. Surprisingly, Sn appeared to be taken into solution more readily 254 
than In. Indium remained below 10 ppb and showed a negative correlation with time at In 255 
(ppb) = 6.58 t
-0.22
 (R² = 0.63), while Sn reached 60 ppb and displaying a positive correlation 256 
along Sn (ppb) = 9.69 t
0.32
 (R² = 0.87). The In/Sn evolved along a trend of In/Sn (w/w) = 0.68 257 
t
-0.54
 (R² = 0.82). As above, the negative correlation of In with time can be explained by 258 
adsorption to the container walls (Robertson, 1968; Smith, 1973). The In blank was 3.39 ± 259 
4.06 ppb and the Sn blank was 0.95 ± 0.51 ppb. 260 
The deep lung environment (simulated with the ALF solution), in contrast, displayed 261 
significant dissolution of the ITO (Figure 4) with maximum concentrations after 480 hrs 262 
reaching 236 ppm In and 8.4 ppm Sn. The increase in concentrations of In and Sn follow best 263 
fit regressions of In (ppb) = 4276 t
0.61
 (R² = 0.97) and Sn (ppb) = 642 t
0.42
 (R² = 0.99). The 264 
In/Sn of the fluid increased over time along a best of In/Sn (w/w) = 6.66 t
0.18
 (R² = 0.71), 265 
showing differential dissolution of In relative to Sn. 266 
The stomach environment (simulated with the PBET solution) similarly displayed 267 
significant dissolution of ITO with concentrations increasing systematically over time (Figure 268 
5). Maximum concentrations after 4 hours were 3.6 ppm In and 127 ppb Sn. Regressions are 269 
for In (ppb) = 2092 t
0.34
 (R² = 0.95) and Sn (ppb) = 72.6 t
0.39
 (R² = 0.93). The In/Sn ratio 270 
showed little variation over time at In/Sn (w/w) = 28.84 t
-0.05
 (R² = 0.36). Blanks were 271 
systematically below 1 ppb In and 0.2 ppb Sn. 272 
Experiments with trypsin (Figure 6) showed In reaching a stable concentration of 901 273 
± 107 ppb in solution in less than 18 hours. The best fit correlation for In (ppb) = 876 t
0.01
 is 274 
not convincing (R² = 0.01). The Sn concentration displayed a decrease in concentration along 275 
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a trend of Sn (ppb) = 46.57 t
-0.33
 (R² = 0.27). A slight increase in In/Sn (ppb) = 12.5 t
0.36
 (R² = 276 
0.04) over time is unconvincing. The average of 9 blank measurements yielded 1.67 ± 1.07 277 
ppb In and <0.05 ppb Sn. 278 
When the different results are compared (Figure 7), it is clear that by far the most 279 
extensive potential for release of In and Sn from ITO is in the simulated deep lung 280 
environment (Figure 7a, b). Although the dissolution rates were nearly as high in the stomach 281 
environment, the much shorter particle residence time effectively limited the concentrations 282 
that could be reached. Although In may be subject to further dissolution in the pancreatic 283 
juice, the total fluid concentrations that can be reached during digestion remains much lower 284 
than the deep lung environment. The simulated upper lung environment displays almost no 285 
dissolution of In, while Sn is very weakly soluble – although at a rate that is nearly 100 times 286 
lower than in the deep lung environment. Selective leaching, expressed by In/Sn is 287 
particularly strong in the upper lung environment (selective leaching of Sn) and in deionised 288 
water (selective leaching of In). The simulated deep lung and stomach environments as well 289 
as the pancreatic juice are much less selective of metals during leaching.  290 
 291 
5. Discussion 292 
Although In is more common in the continental crust than silver (Rudnick and Gao, 293 
2003), little is known about the environmental dispersal of the most commonly used In 294 
compounds (White and Hemond, 2012). Most toxicological studies focus on ITO factories, 295 
where workers are exposed to particularly high concentrations of the metal in various forms.  296 
While In is primarily recovered through chemical leaching, the recycling business, in 297 
particular, employs mechanical abrasion (sand blasting, sanding, wet grinding) to liberate 298 
ITO (Hines et al., 2013, Zeng et al., 2015; Zhang et al., 2015), releasing nano- and micro-299 
particles into the air that may be inhaled. Most medical studies consequently focus on 300 
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respiratory disorders, as recently evaluated by Cummings et al. (2012), who associated ITO 301 
with pulmonary alveolar proteinosis, pulmonary fibrosis, emphysema, and pneumothoraces. 302 
Although Zheng et al. (1994) suggested that In is poorly absorbed in the body, Nagano et al. 303 
(2011) suggested (based on a study of rats) that in addition to the lungs, the metal may also 304 
concentrate in the spleen, kidney and liver. The study by Chen (2007) suggests that some In 305 
is eventually excreted, and while the study by Morrow et al. (1957) suggests a short  306 
biological half-life (in the order of a couple of weeks), Amata et al. (2015) consider that 307 
actual residence times in humans to be as high as 8 years. It is worth noting that while the 308 
study by Morrow et al. (1957) was based on a single dose of In, Amata et al. (2015) 309 
considered the effects of long term exposure, a situation that is much more relevant to 310 
workers exposed to ITO.  311 
Sintering of ITO is a solid-state process that aims to generate a technological material 312 
by solid-state diffusion and particle annealing. It is an inherently inhomogeneous process that 313 
leads to a metastable product (Heward and Swenson, 2007). The observed structure and 314 
compositional variability of the ITO powder is consistent with the expected variability in 315 
industrial products and the structure of ITO coatings (Thirumoorthi and Thomas Joseph 316 
Prakash, 2016). The presence of discrete SnO2 particles is consistent with incomplete reaction 317 
or local supersaturation, as explained by Kim et al. (2006). The particles are coarser than 318 
those that are likely to be liberated from ITO coatings, and as the dissolution rate is likely to 319 
be a function of the surface area, this implies that the dissolution is likely to be faster than 320 
during our experiments. The structure and compositional variation, however, are sufficiently 321 
similar to suggest that our results provide a reasonable analogue of ITO particles that are 322 
liberated from the production and recycling of flat screen devices.  323 
Sintered ITO remains a hardly soluble compound when compared to other In 324 
compounds such as In-phosphide, In-arsenide In-trichloride and In-acetate (Chapin et al., 325 
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1995; Oda, 1997; Tanaka, 2004, Lee et al., 2016). Our study demonstrates that ITO is nearly 326 
insoluble under simulated upper respiratory tract conditions and in deionized water, while it 327 
displays some dissolution in the simulated deep lung and stomach environments. 328 
Surprisingly, the In concentrations in the simulated upper respiratory tract conditions 329 
(Gamble’s solution), deionized water, and deionized water with trypsin display negative 330 
correlations with time, suggesting that the metal is removed from solution over time. 331 
Robertson (1968) and Smith (1973) documented that In is readily lost from solution unless 332 
kept at low pH. They concluded that the metal adsorbs to (or is absorbed into) plastic 333 
containers. All of these solutions have near neutral pH, and we consider metal loss to the 334 
containers to adequately explain the negative trends.  335 
When inhaled as airborne micro- and nano-particles (Figure 8), our tests with 336 
Gamble’s solution suggest that ITO is likely to largely remain as solid particles as long as 337 
they rest in the upper respiratory tract or tracheobronchial tree. The ITO particles could 338 
possibly cause some mechanical irritation but they remain fairly inert in this environment. 339 
Very minor differential leaching of Sn is possible, although this is unlikely to be of medical 340 
concern. It is interesting that the solubility of In is much lower than in deionised water, 341 
indicating that the solubility is negatively affected by the dissolved salts. 342 
Upon contact with the more acidic fluids associated with the deep parts of the lungs 343 
(the bronchioles and alveoli), the ITO will release In
3+
 and Sn
4+
 into solution. Our 344 
experiments did not plateau at a saturation level, which at least must be higher than the 236 345 
ppm In and 8.5 ppm Sn maxima measured at 480 hours. Our results suggests that In in this 346 
environment is able to transfer into the bloodstream for wider dissemination through the 347 
human body. The low, but systematic solubility combined with the very long potential 348 
residence times for ITO in the deep parts of the lungs suggest that this is the dominant route 349 
of transfer of metals into the bloodstream. As outlined above, the United States recommended 350 
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inhalation exposure limit indicates that typically 0.67-0.83 mg In could be inhaled an eight 351 
hour working day, leading to a total inhalation of 13.4 – 16.6 mg over a period of 20 working 352 
days. If 25-45% is considered to accumulate in the deep lungs (Jaques and Kim, 2000), the 353 
accumulation over this period would amount to 3.4 – 7.5 mg ITO, of which 2.5 – 5.6 mg 354 
would be In. Our experiments reached fluid concentrations of 236 ppm In, which equates to 355 
the dissolution of 2.36 mg In in the 10 ml test solution over a period of 20 days. If the amount 356 
of extravascular lung water in healthy adults is considered to be 255 ml, as estimated by 357 
Wallin and Leksell (1994), the total volume of fluids would be able to dissolve around 60 mg 358 
In over this period. While the actual In concentrations that may be reached in the deep lung 359 
fluids would depend on the ITO accumulation rates, fluid availability and clearance rates, the 360 
scale and scope of our experiments appear entirely realistic for human intake. 361 
The ITO is also likely to slowly decompose in the acid environment of the stomach 362 
(Figure 8) leading to the release of In and, to a lesser extent Sn. As for the deep lung 363 
environment, the concentrations didn’t plateau, and the solubility must at least exceed the 364 
measured maximum concentrations of 3 ppm In and 120 ppb Sn. However, it is notable from 365 
other laboratory experiments that the solubility of In appears to be strongly pH dependent 366 
(Smith, 1973), and it is likely that the dissolution rate will vary substantially during the 367 
digestive cycle. Minor further decomposition may occur in the pancreatic juice, where trypsin 368 
(and possibly other enzymes) facilitate dissolution. The digestive tract, consequently, offers 369 
another route for intake of the In and Sn. However, despite comparable rates of dissolution to 370 
the deep lung environment, the much shorter residence times lead to much lower 371 
concentrations. The metal transfer through the digestive tract would consequently be much 372 
less significant. 373 
While we are not in a position to properly evaluate the wider toxicological effects of 374 
ITO, we note that the effects of inhalation is likely not to be restricted to the lung 375 
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environment. Over time, In and Sn become mobilized into the bloodstream through the 376 
bronchioles and alveoli, and therefore circulate more widely throughout the body. Once taken 377 
into the bloodstream, given the low pH of the deep lung fluids and the stomach acid, the In 378 
would be likely to take the form of ionic In
3+
 and bind to plasma transferrin (Hosain et al., 379 
1969) before eventually being deposited in the kidneys (Smith et al., 1978). The actual 380 
concentrations that can be reached will primarily depend on how fast the deep lung fluids are 381 
replenished and cleared. Ionic In in the bloodstream can be expected to have similar health 382 
effects as other soluble In-salts, particularly Lewis acids such as In-trichloride. Although In 383 
may eventually be excreted (Chen, 2007), it is important to develop an understanding of the 384 
potential health effects that could occur more widespread throughout the body through 385 
prolonged exposure to ITO. 386 
With the wider environmental dispersion as ITO hits the domestic waste routes, it is 387 
likely that adverse health effects may spread much more widely than to ITO factory workers. 388 
The most likely people at risk would be scrapyard workers and people involved with 389 
recycling of electronic and domestic waste (Zeng et al., 2015), particularly in developing 390 
countries where environmental controls are poorly developed (Robinson, 2009; Lim and 391 
Schoenung, 2010). While the effects of Sn are well constrained, the largely unknown 392 
behavior of In in the surface environment is worrying. It is surprising that In is considered to 393 
be fairly harmless, when most of the nearest neighbors in the periodic table (Sn, Cd, Hg, Tl, 394 
Pb) are associated with severe adverse health and environmental effects. The wide global 395 
dissemination of In leads to concerns about the potential risks that could be caused by the 396 
disposal of electronic devices with flat screen displays through the domestic waste routes. 397 
Further work is urgently needed to understand how the likely widespread release of In from 398 
ITO may affect the environment. 399 
 400 
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6. Conclusions 401 
While ITO appears to be nearly inert in the upper parts of the respiratory system, In 402 
and Sn are likely to be released into fluids in the deep parts of the lungs. At current exposure 403 
limits, accumulation rates could potentially reach 50 mg in less than a year for workers 404 
exposed to ITO during daily 8 hour working shifts. Concentrations in deep lung fluids could 405 
potentially exceed 236 ppm In and 8.5 ppm Sn leading to significant transfer of the metals 406 
into the bloodstream. In the digestive tract, In and Sn are also released from ITO in the 407 
stomach, where further release may be facilitated by enzymes in the pancreatic juice. 408 
However the much shorter residence time indicates a much lower risk of metal uptake 409 
through digestion.  410 
Dissolution of ITO from inhaled nano- and microparticles in the deep lung fluids is 411 
likely to be the most significant mechanism for transfer of In (and Sn) into the bloodstream. 412 
As dissolved metal ions circulate through the human body, the exposure may lead to health 413 
damage outside of the environment of the lungs. In this context, the poor knowledge of the 414 
environmental properties and potential toxicity of In are immediate causes of concern with 415 
respect to the distribution of In-compounds across the human society. 416 
 417 
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Figure captions 595 
Figure 1. Backscattered electron image (COMP, compositional contrast) of a polished block 596 
of the ITO powder. The image shows ITO particles (bright) embedded in epoxy resin (dark) 597 
and polished to a flat surface. Particle outlines represent transects through individual 598 
particles. Particles are generally rounded aggregates of hollow spheres with high surface to 599 
volume ratios. The scale bar is 10 µm. 600 
 601 
Figure 2. Concentrations of In (A) and Sn (B) and the In-Sn ratio (C) measured in deionized 602 
water in contact with ITO powder. The negative correlations of In and Sn with time are likely 603 
to be caused by sorption of metals to the container walls (Robertson, 1968; Smith, 1973). 604 
 605 
Figure 3. Concentrations of In (A) and Sn (B) and the In-Sn ratio (C) measured in simulated 606 
upper respiratory tract fluids (Gamble’s solution) in contact with ITO powder. As for figure 607 
2, the negative correlation of In with time is likely to be caused by sorption to the container 608 
walls. The substantial decrease in In/Sn over time is a combined effect of In removal and Sn 609 
dissolution. 610 
 611 
Figure 4. Concentrations of In (A) and Sn (B) and the In-Sn ratio (C) measured in simulated 612 
deep lung fluids (the ALF solution) in contact with ITO powder. In and Sn display strong 613 
positive correlations with time. The evolution in In/Sn demonstrates selective dissolution of 614 
In. 615 
 616 
Figure 5. Concentrations of In (A) and Sn (B) and the In-Sn ratio (C) measured in the 617 
simulated stomach acid (the PBET solution) in contact with ITO powder. In and Sn display 618 
  28 
strong positive correlations with time. This environment is not particularly selective in the 619 
dissolution of In and Sn. 620 
 621 
Figure 6. Concentrations of In (A) and Sn (B) and the In-Sn ratio (C) measured for deionized 622 
water with trypsin in contact with ITO. The results indicate that trypsin may facilitate the 623 
dissolution of In in the pancreatic fluid to concentrations that are nearly as high as those in 624 
the simulated stomach acid. 625 
 626 
Figure 7. Comparison of the dissolution of In (A), Sn (B) and the In-Sn ratio (C) for the 627 
different experiments illustrated in figures 2-6. The figure highlights the significance of the 628 
deep lung environment in the dissolution of inhaled ITO. Concentrations obtained by 629 
dissolution in stomach acid and the pancreatic juice (trypsin assisted), while potentially also 630 
significant, are limited by the shorter particle residence time. 631 
 632 
Figure 8. Schematic illustration of the main routes of ITO uptake in the human body. The 633 
most significant route of uptake is through inhalation where the most significant metal 634 
transfer is likely to occur in the deep lung fluids. Digestion is another potential route for 635 
metal uptake, although the shorter residence time is likely to limit the magnitude of metal 636 
transfer. 637 
 638 
Chemical compound Chemical formula 
ALF 
solution 
Gamble's 
solution 
PBET 
solution 
Magnesium chloride MgCl2 0.05 g/L 0.10 g/L - 
Sodium chloride NaCl 3.20 g/L 6.00 g/L - 
Potassium chloride KCl - 0.30 g/L - 
Disodium hydrogen phosphate Na2HPO4 0.07 g/L 0.13 g/L - 
Sodium sulphate Na2SO4 0.04 g/L 0.07 g/L - 
Calcium chloride dihydrate CaCl2  x 2H2O 0.13 g/L 0.37 g/L - 
Sodium acetate NaC2H3O2 - 0.57 g/L - 
Sodium hydrogen carbonate NaHCO3 - 2.60 g/L - 
Sodium citrate dihydrate Na3C6H5O7 x 2H2O 0.08 g/L 0.10 g/L 0.50 g/L 
Sodium hydroxide NaOH 6.00 g/L - - 
Citric acid C6H8O7 20.80 g/L - - 
Glycine NH₂-CH₂-COOH 0.06 g/L - - 
Sodium tartrate dihydrate Na2C4H4O6 x 2H2O 0.10 g/L - - 
Sodium lactate NaC3H5O3 0.10 g/L - - 
Sodium pyruvate NaC3H3O3 0.10 g/L - - 
Pepsin 
 
- - 1.25 g/L 
Malic acid C4H6O5 - - 0.50 g/L 
Lactic acid C3H6O3 - - 420 µL/L 
Acetic acid CH3COOH - - 500 µL/L 
pH (adjusted with concentrated HCl) 
 
4.5 7.5 4.0 
 
Table 1. Weight and volumes of material for the simulation of the deep lung environment (artificial 
lysosomal fluid, ALF), the upper respiratory tract (Gamble’s solution) and the stomach environment 
(physiologically based extraction test, PBET). The ALF and Gamble’s solutions follow the formulations 
of Colombo et al. (2008) while the PBET follows Ruby et al. (1996). 
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